Interwell Health is at the forefront of transforming kidney care, driven by a commitment to groundbreaking technology and industry advancement. The company is revolutionizing how kidney disease is managed by integrating innovative technology solutions designed to improve patient outcomes and streamline care delivery. A key example of this is the Acumen Rounder, a nephrology rounding app that tightly integrates with Epic EHR, showcasing Interwell Health's dedication to technology-driven patient care. This focus on tech-savviness aims to enhance the overall healthcare experience for both patients and providers. By leveraging data analytics capabilities, Interwell Health identifies high-risk patients early, enabling timely interventions. Their patient engagement platform delivers both in-person and virtual clinical support, ensuring continuous and comprehensive care. This innovative approach extends to providing real-time access to multidisciplinary care teams and patient peer mentors, fostering a supportive and informed patient journey.
The company's mission is to reimagine healthcare with expertise, compassion, and a clear vision to set new industry standards, ultimately helping patients live their best lives. Interwell Health partners with a vast network of physicians, empowering them with the resources and technological tools needed to thrive in a value-based care environment. This includes personalized patient education, proprietary predictive models, and embedded care coordinators within practices. Furthermore, Interwell Health offers its own instance of Epic, the most widely adopted nephrology-specific electronic health record, to enhance care coordination and efficiency. Their interdisciplinary care teams, consisting of social workers, nurses, and dietitians, provide crucial support to patients between doctor visits. Through these technological advancements and a patient-centric philosophy, Interwell Health is dedicated to slowing disease progression, reducing hospitalizations, and improving the quality of life for individuals with kidney disease, while also aiming to lower the total cost of care for payer partners.
United States only